A

Astec Lifesciences Ltd
NSE:ASTEC

Watchlist Manager
Astec Lifesciences Ltd
NSE:ASTEC
Watchlist
Price: 627.85 INR 1.16%
Market Cap: ₹14.1B

Balance Sheet

Balance Sheet Decomposition
Astec Lifesciences Ltd

Balance Sheet
Astec Lifesciences Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2004 Mar-2005 Mar-2006 Mar-2007 Mar-2008 Mar-2009 Mar-2010 Mar-2011 Mar-2012 Mar-2013 Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024 Mar-2025
Assets
Cash & Cash Equivalents
4
4
9
12
16
11
1
7
9
20
45
120
61
42
3
2
3
3
6
0
24
27
Cash
4
4
9
12
16
11
1
7
9
20
45
7
23
28
3
2
3
3
6
0
5
6
Cash Equivalents
0
0
0
0
0
0
0
0
0
0
0
113
38
14
0
0
0
0
0
0
20
21
Short-Term Investments
0
0
0
0
0
0
0
80
118
0
1
5
9
6
0
0
0
0
0
0
20
6
Total Receivables
41
87
93
169
236
331
398
454
452
627
538
844
904
1 107
1 503
1 512
2 021
2 177
3 127
1 952
1 925
1 712
Accounts Receivables
28
55
55
111
180
288
324
343
319
33
514
842
806
1 107
1 232
1 218
1 608
1 872
2 736
1 952
1 920
1 685
Other Receivables
13
32
37
58
57
43
75
111
134
594
24
2
98
1
272
293
413
306
391
0
6
28
Inventory
55
54
121
124
188
291
333
369
504
507
766
681
713
656
786
936
1 219
1 072
1 912
2 961
1 972
1 620
Other Current Assets
0
0
0
0
0
0
32
0
0
32
0
106
226
173
24
35
74
52
112
71
83
74
Total Current Assets
99
145
223
304
440
632
763
909
1 083
1 186
1 349
1 757
1 912
1 984
2 317
2 485
3 318
3 304
5 157
4 989
3 985
3 411
PP&E Net
37
62
130
215
335
330
515
815
1 196
1 337
1 381
962
1 112
1 070
1 541
1 835
2 142
3 232
3 514
4 292
5 316
4 967
PP&E Gross
37
62
130
215
335
330
515
0
1 196
1 337
0
0
0
0
1 541
1 835
2 142
3 232
3 514
4 292
5 316
4 967
Accumulated Depreciation
16
8
15
29
67
100
142
0
284
401
0
0
0
0
324
509
733
983
1 319
1 635
1 996
2 430
Intangible Assets
0
0
0
0
0
0
0
0
2
1
0
32
33
35
29
24
36
52
114
159
194
234
Note Receivable
0
0
0
0
0
0
0
12
33
86
115
0
26
31
127
146
106
73
87
355
254
201
Long-Term Investments
0
0
0
1
1
1
258
1
0
1
0
49
50
46
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
3
2
6
0
0
2
1
0
0
0
200
165
170
119
120
117
115
96
96
97
105
Total Assets
137
N/A
209
+53%
355
+69%
526
+48%
777
+48%
963
+24%
1 537
+60%
1 737
+13%
2 314
+33%
2 611
+13%
2 845
+9%
3 000
+5%
3 297
+10%
3 336
+1%
4 132
+24%
4 611
+12%
5 717
+24%
6 776
+19%
8 968
+32%
9 794
+9%
9 749
0%
8 814
-10%
Liabilities
Accounts Payable
0
0
0
0
0
0
145
229
310
461
457
709
680
571
999
633
2 024
1 248
1 898
1 772
893
816
Short-Term Debt
0
0
0
0
0
0
0
389
592
472
573
775
1 086
1 260
1 242
1 757
987
1 470
2 394
2 853
2 830
2 644
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
23
9
10
0
0
0
0
2
0
0
2
400
450
119
102
Other Current Liabilities
60
98
90
133
217
202
77
36
54
81
143
226
264
107
141
99
173
503
214
187
130
96
Total Current Liabilities
60
98
90
133
217
202
222
676
965
1 023
1 172
1 710
2 030
1 937
2 384
2 488
3 184
3 223
4 906
5 262
3 972
3 657
Long-Term Debt
24
46
153
231
332
440
367
24
118
215
181
128
82
4
3
0
0
400
0
109
1 990
2 800
Deferred Income Tax
5
6
8
10
13
14
17
24
23
39
37
0
0
12
45
93
61
55
81
210
68
0
Minority Interest
0
0
0
0
2
2
2
2
2
1
0
1
1
2
3
3
3
1
2
2
2
3
Other Liabilities
0
0
0
0
0
0
0
42
222
276
320
7
5
1
2
2
3
5
14
18
25
7
Total Liabilities
89
N/A
150
+69%
250
+67%
373
+49%
563
+51%
658
+17%
608
-8%
769
+26%
1 329
+73%
1 553
+17%
1 710
+10%
1 846
+8%
2 117
+15%
1 956
-8%
2 435
+25%
2 586
+6%
3 252
+26%
3 684
+13%
5 003
+36%
5 601
+12%
6 056
+8%
6 467
+7%
Equity
Common Stock
5
5
5
9
94
94
169
169
169
180
185
195
195
195
195
196
196
196
196
196
196
196
Retained Earnings
43
54
87
144
128
224
319
359
376
410
950
960
986
1 185
914
1 236
1 674
2 293
3 163
3 386
2 882
1 536
Additional Paid In Capital
0
0
12
0
0
0
562
440
440
467
0
0
0
0
580
586
589
598
604
607
611
614
Other Equity
0
0
0
0
9
13
122
0
0
0
0
0
0
0
7
8
7
4
3
4
4
1
Total Equity
48
N/A
60
+24%
104
+75%
153
+46%
214
+40%
305
+43%
929
+204%
968
+4%
985
+2%
1 058
+7%
1 135
+7%
1 155
+2%
1 180
+2%
1 380
+17%
1 697
+23%
2 025
+19%
2 466
+22%
3 092
+25%
3 965
+28%
4 194
+6%
3 693
-12%
2 347
-36%
Total Liabilities & Equity
137
N/A
209
+53%
355
+69%
526
+48%
777
+48%
963
+24%
1 537
+60%
1 737
+13%
2 314
+33%
2 611
+13%
2 845
+9%
3 000
+5%
3 297
+10%
3 336
+1%
4 132
+24%
4 611
+12%
5 717
+24%
6 776
+19%
8 968
+32%
9 794
+9%
9 749
0%
8 814
-10%
Shares Outstanding
Common Shares Outstanding
9
9
9
9
9
9
17
17
17
18
19
20
20
20
20
20
20
20
20
20
20
20
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett